Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
The most frequent cause of trial failure stems from the inability to meet patient enrollment goals. Revolutionize your investigator and site selection process utilizing Sitetrove’s comprehensive suite of intel, including specialty qualifications, historical trial experience, current competitive commitments and up-to-date contact details, all verified and confirmed by one of our expert analysts.
With over 500,000 investigators and more than 180,000 clinical trial sites spanning 185 countries, Sitetrove brings you the vital information you need to accurately assess target locations, identify qualified investigators, and prioritize candidates to make your trial a success.
|Identify verified investigators and assess experience and competitive engagements|
|Leverage our validated prioritization mechanism to rank investigator results into tiers|
|Analyze real world data to understand patient access and better inform selection|
|Evaluate key metrics at both the organization and parent organization levels|
Prioritize your investigators using our proprietary algorithm and ensure you are considering individuals with the highest probability of performing well, on average and as a group, in a specific disease area. Real world patient data further enriches the selection process, ensuring you are employing investigators with strong patient connections.
With our industry-leading platform you can:
You can also access Sitetrove via our Investigators & Organizations API so you can integrate, connect, and deliver multiple sources of information in real-time.
Sitetrove also offers seamless integration with Trialtrove and Pharmaprojects, our clinical trials and drug development intelligence solutions.
We have received your request and we will get back to you soon.